Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma
Cancer Science, 11/02/09
Shimada K et al. – The percentage of cancer cells positive for syndecan–1 at initial diagnosis was statistically associated with the frequency of bladder cancer recurrence after transurethral resection. In conclusion, syndecan–1 might contribute to urothelial carcinoma cell survival and progression; therefore, this molecule could be a new therapeutic target in human urinary bladder cancer.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Isolation and Characterization of Spheroid Cells from Human Malignant Melanoma Cell Line WM-266-4
Tumor Biology, 11/24/09
Targeting Vascular Endothelial Growth Factor in Renal Cell Carcinoma
Tumor Biology, 11/24/09
Regulation of Clusterin Expression in Human Cancer via DNA Methylation
Tumor Biology, 11/24/09
Today in Renal/Urologic...keeping you current
Receive free subspecialty "5-minute updates" via email
Targeting Vascular Endothelial Growth Factor in Renal Cell Carcinoma
Tumor Biology, 11/24/09
Prospective studies of dietary alpha-linolenic acid intake and prostate cancer risk: a meta-analysis
Cancer Causes and Control, 11/24/09
Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer
Annals of Oncology, 11/24/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


